Table 1.
Clinicopathological features | No. of patients | LINC00941 expression | ||||
---|---|---|---|---|---|---|
M ± SD | P-value (u test) | HIGH | LOW | P-value (chi-squared test) | ||
Gender | ||||||
Male | 229 | 13.2948 ± 2.1672 | 0.075 | 108 | 121 | 0.1524 |
Female | 129 | 13.7071 ± 2.2679 | 71 | 58 | ||
Histological type | ||||||
Intestinal | 157 | 13.4669 ± 2.2533 | 0.324 | 83 | 74 | 0.1936 |
Diffuse | 69 | 13.1354 ± 1.9947 | 30 | 39 | ||
Neoplasm histologic grade | ||||||
G1+G2 | 138 | 13.3593 ± 2.2462 | 0.722 | 67 | 71 | 0.6931 |
G3 | 211 | 13.5146 ± 2.1727 | 107 | 104 | ||
Pathological T | ||||||
I/II | 89 | 13.0108 ± 2.1219 | 0.018∗ | 35 | 54 | 0.0197∗ |
III/IV | 261 | 13.5589 ± 2.2355 | 140 | 121 | ||
Pathological N | ||||||
N0 | 104 | 13.089 ± 2.2773 | 0.0184∗ | 45 | 59 | 0.0994 |
N1-3 | 236 | 13.6186 ± 2.1909 | 125 | 111 | ||
Pathological M | ||||||
M0 | 316 | 13.3147 ± 2.2169 | 0.003∗ | 152 | 164 | 0.0111∗ |
M1 | 24 | 14.6567 ± 1.7331 | 18 | 6 | ||
Tumor stage | ||||||
Stage I–II | 154 | 13.202 ± 2.2414 | 0.042∗ | 70 | 84 | 0.1129 |
Stage III–IV | 181 | 13.6303 ± 2.2126 | 98 | 83 | ||
∗The values had statistically significant differences.
M, the average expression level; SD, the standard deviation of expression level; Pathological T, tumor depth; Pathological N, lymph nodes affected; Pathological M, distant metastasis.